Advances in high-resolution MS and hepatocyte models solve a long-standing metabolism challenge: the loratadine story.
Article Details
- CitationCopy to clipboard
Aratyn-Schaus Y, Ramanathan R
Advances in high-resolution MS and hepatocyte models solve a long-standing metabolism challenge: the loratadine story.
Bioanalysis. 2016 Aug;8(16):1645-62. doi: 10.4155/bio-2016-0094. Epub 2016 Jul 27.
- PubMed ID
- 27460981 [ View in PubMed]
- Abstract
BACKGROUND: Loratadine (LOR, Claritin((R))) is a long-acting antihistamine used to treat allergic rhinitis. The major active human metabolite, desloratadine (DL, Clarinex((R))), is extensively metabolized to 3-hydroxydesloratadine (3-OH-DL) (M40) and subsequently glucuronidated before elimination. This study revealed the ability of a novel, long-term hepatocyte micropatterned co-culture (MPCC) model to generate in vivo metabolites. Metabolites were detected and characterized using non-targeted MS/MS(ALL) with SWATH acquisition by a UHPLC-Q-TOF system. Results & methodology: Human MPCCs extensively metabolized LOR and formed 3-OH-DL-glucuronide (M13). Cross-species comparisons revealed monkey- and rat-specific metabolites with gender-specific DL-pyridine-N-oxide formation in male rats. These results demonstrate a first for an in vitro hepatocyte model to generate circulating metabolites of LOR and detect species-specific differences. Early focus on human metabolites could have spared characterization of nonhuman metabolites in preclinical species.
DrugBank Data that Cites this Article
- Drugs
- Drug Enzymes
Drug Enzyme Kind Organism Pharmacological Action Actions Loratadine Cytochrome P450 1A1 Protein Humans NoSubstrateDetails Loratadine Cytochrome P450 2C19 Protein Humans NoSubstrateInhibitorDetails Loratadine UDP-glucuronosyltransferase 1-1 Protein Humans UnknownNot Available Details Loratadine UDP-glucuronosyltransferase 1-3 Protein Humans UnknownNot Available Details Loratadine UDP-glucuronosyltransferase 2B15 Protein Humans UnknownNot Available Details - Drug Reactions
Reaction Details Details